Agilent, SAT Ink Pact to Provide Automated SISCAPA Workflows for Protein Quantitation | GenomeWeb

NEW YORK (GenomeWeb) – Agilent Technologies and SISCAPA Assay Technologies said today that they have signed a non-exclusive agreement to provide complete workflows for targeted protein quantitation.

The workflows combine SAT's SISCAPA reagents for immunoenrichment mass spec-based protein quantitation with Agilent's Bravo automated liquid handling platform for sample prep and LC/MS systems, including Agilent's RapidFire high-throughput LC/MS system, for quantitative analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: statistical approach to examine intra-tumor heterogeneity, new genetic condition called otulipenia, and more.

Blood tests looking for biomarker changes could catch mental illnesses earlier, Newsweek reports.

DNA testing offers Korean adoptees a way to find their birth parents that sidesteps bureaucratic red tape, according to the New York Times.

A National Institutes of Health researcher has filed an Equal Employment Opportunity complaint against the agency, the Washington Post reports.